Purpose: The purpose of this article is to assess the diagnostic performance of arterial spin-labeling (ASL) magnetic resonance perfusion imaging to differentiate neoplastic from non-neoplastic brain lesions. Material and methods: This prospective study included 60 consecutive, newly diagnosed, untreated patients with intra-axial lesions with perilesional edema (PE) who underwent clinical magnetic resonance imaging including ASL sequences at 3T. Region of interest analysis was performed to obtain mean cerebral blood flow (CBF) values from lesion (L), PE and normal contralateral white matter (CWM). Normalized (n) CBF ratio was obtained by dividing the mean CBF value of L and PE by mean CBF value of CWM. Discriminant analyses were performed to determine the best cutoff value of nCBFL and nCBFPE in differentiating neoplastic from non-neoplastic lesions. Results: Thirty patients were in the neoplastic group (15 high-grade gliomas (HGGs), 15 metastases) and 30 in the nonneoplastic group (12 tuberculomas, 10 neurocysticercosis, four abscesses, two fungal granulomas and two tumefactive demyelination) based on final histopathology and clincoradiological diagnosis. We found higher nCBFL (6.65 AE 4.07 vs 1.68 AE 0.80, p < 0.001) and nCBFPE (1.86 AE 1.43 vs 0.74 AE 0.21, p < 0.001) values in the neoplastic group than nonneoplastic. For predicting neoplastic lesions, we found an nCBFL cutoff value of 1.89 (AUC 0.917; 95% CI 0.854 to 0.980; sensitivity 90%; specificity 73%) and nCBFPE value of 0.76 (AUC 0.783; 95% CI 0.675 to 0.891; sensitivity 80%; specificity 58%). Mean nCBFL was higher in HGGs (8.70 AE 4.16) compared to tuberculomas (1.98 AE 0.87); and nCBFPE was higher in HGGs (3.06 AE 1.53) compared to metastases (0.86 AE 0.34) and tuberculomas (0.73 AE 0.22) (p < 0.001). Conclusion: ASL perfusion may help in distinguishing neoplastic from non-neoplastic brain lesions.
Introduction
Contrast magnetic resonance imaging (MRI) has a well-established role in brain lesion evaluation by providing anatomical information; however, it has a limited role in the quantitative and functional assessment of lesions thus making it less reliable in differentiating tumors from tumor-like lesions. Contrast enhancement depicts blood-brain barrier (BBB) impairment, so every lesion that shows contrast enhancement is not a tumor and every glioma that does not take contrast is not a low-grade glioma and vice versa. 1 Perfusion-weighted imaging (PWI) serves as a useful adjunct to conventional MRI and overcomes these limitations by estimating tumor neoangiogenesis, which helps in tumor grading, guiding stereotactic biopsy and surgical planning. Dynamic susceptibility contrast (DSC), routinely used with PWI in clinical practice, uses an exogenous gadolinium contrast agent and provides relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) parameters that correlate well with tumor grade and histology. 2 Arterial spin labeling (ASL) is a noninvasive PWI method that provides absolute quantification of CBF in the absence of exogenous contrast, which makes ASL a promising technique for studying perfusion in patients with allergies, renal failure, difficult intravenous access, repetitive follow-ups, pregnant women and children. 3 DSC is preferred over ASL in brain lesion evaluation because of routine contrast administration and rapid data acquisition. However, in contrast-enhanced perfusion techniques, CBF quantification is affected by T1 and T2 effects of BBB disruption and susceptibility artifacts, which are less with ASL. 4 Previous studies have shown a very strong correlation between ASL and DSC-MRI derived perfusion parameters for evaluation of brain tumors and support the possibility that ASL can be used as an alternative to DSC-MRI. [5] [6] [7] Gliomas are the most common primary brain tumors and sometimes differentiation from solitary enhancing cerebral metastases can be difficult on conventional MRI. Primary tumors have shown statistically significant higher perfusion in perilesional edema (PE) compared to metastases that have been ascribed to tumor infiltration along white matter tracts in glioma. [8] [9] [10] [11] [12] Contrast enhancements of infective brain lesions is due to disrupted BBB and lack of angiogenesis in enhancing lesions on PWI favors non-neoplastic origin, which helps to differentiate them from tumors. In endemic countries, tuberculosis (TB) and neurocysticercosis (NCC) are the most frequent infective brain lesions and are sometimes difficult to differentiate from primary brain tumors and metastases on conventional MRI. [13] [14] [15] In this study, we evaluated the practicability of ASLderived CBF parameters in differentiation of various intra-axial lesions in our population and assessed the feasibility of using ASL as an alternative to DSC when needed.
Materials and methods

Participants
This prospective study protocol (July 2014 through December 2016) was approved by our institute's ethics committee and all participants provided written informed consent at the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. We included 60 consecutive, newly diagnosed, untreated patients (mean age 39 years; age range 18-66 years; male:female 34:26) with single or multiple enhancing intra-axial brain lesions of size more than 1 cm with perilesional edema (PE) detected either on computed tomography or MRI. We excluded patients with any form of prior specific medical or surgical treatment, unknown disease, and lesions less than 1 cm.
MRI study
MRI examination was performed with a 3 T MR scanner (Signa Hdxt, General Electric, Milwaukee, WI, USA), using a 12-channel head coil. Routine imaging protocols included axial T2, T1/T2 fluid-attenuated inversion recovery (FLAIR), diffusion-weighted imaging (DWI) (b value ¼ 0 and 1000 mm 2 /sec) and post-contrast T1. Whole-brain three-dimensional pseudocontinuous ASL (3D PCASL) was acquired with the following parameters: label duration ¼ 1. Post-processing and data analysis ASL data were transferred to the workstation (ADW4.4, GE, USA) for post-processing and analyzed using commercial software (FuncTool BrainStat Software, General Electric, Milwaukee, WI, USA) with automated generation of quantitative perfusion CBF maps. Conventional MRI and perfusion maps were co-analyzed by two subspecialty neuroradiologists (reader 1, with 10 years' experience, and reader 2, with 35 years' experience) in consensus who were blinded to the final diagnosis. The conventional MR sequence assessed the lesion localization, characterization and PE on T2 FLAIR. CBF values were calculated by positioning three circular regions of interest (ROIs) (5-10 mm 2 ) over the lesions showing highest perfusion signal as visually determined from the CBF maps and from the nonenhancing PE (within 1 cm from the lesion) excluding necrotic, cystic and hemorrhagic areas ( Figure 1 ).
To minimize measurement errors of CBF analysis, uniformly sized ROIs (5-10 mm 2 ) were kept and targeted to the maximal abnormalities within the lesion. An average of three CBF measurements were taken and in cases of multiple lesions, the larger lesion with maximum perfusion value was targeted for measurements. For normalization to avoid individual patient variation, three similar ROIs were placed on the normal contralateral white matter (CWM) and averaged to obtain mean CWM CBF values. Normalized CBF ratios were calculated by dividing the average CBF from lesion and PE to average CWM CBF (nCBFL and nCBFPE).
Statistical analysis
The normality of continuous variables (ASL parameters) was tested using the Kolmogorov-Smirnov test. For normally distributed data, mean AE standard deviation (SD) was used as descriptive statistics. nCBFL and nCBFPE values between the two groups (neoplastic and non-neoplastic) were compared using the independent t test. Receiver operating characteristic (ROC) curve was performed and area under curve (AUC) calculated to seek the best cutoff values of nCBFL and nCBFPE to differentiate neoplastic from non-neoplastic lesions. Sensitivity, specificity and 95% confidence intervals (CIs) were calculated when employing the cutoff CBF values. A p < 0.05 was considered statistically significant and p < 0.001 highly significant. Statistical analysis was performed using the Statistical Package for Social Sciences, version 23 (SPSS-23, IBM, and Chicago, IL, USA).
Results
All the patients were broadly classified into two major groups of neoplastic (male:female 21:9; age range 38-66 years) and non-neoplastic (male:female 13:17; age range 18-46 years) based on the histopathological and clinicoradiological diagnoses. Histopathology was documented in patients with high-grade gliomas (HGGs) (n ¼ 15), fungal granuloma (n ¼ 2) and presence of primary carcinoma in metastases (n ¼ 15). Clinicoradiologic diagnoses were determined by a combination of provided clinical history, typical imaging findings, biochemical, culture and post-treatment follow-ups in patients with TB (n ¼ 12), NCC (n ¼ 10), abscess (n ¼ 4) and tumefactive demyelination (n ¼ 2). In the neoplastic group, HGGs and metastasis (eight cases of primary carcinoma of the breast, seven cases of primary carcinoma of the lung) comprised the bulk of patients while tuberculoma and NCC predominated in the non-neoplastic group (Table 1) . The mean nCBFL and nCBFPE values of the neoplastic group were compared with those of the non-neoplastic group and are displayed in Table 2 . Statistically significant (p < 0.001) (Table 2) . ROC analysis results indicated that when mean nCBFL ¼ 1.89 was set as the threshold value, the best diagnostic performance in predicting neoplastic lesions was achieved with 90%, sensitivity (95% CI 0.723-0.973) 73%, specificity (95% CI 0.538-0.871) and AUC of 0.917 (95% CI 0.854-0.980) (Figure 1(a) ). When mean nCBFPE ¼ 0.76 was set as the threshold value, the best diagnostic performance in predicting neoplastic lesions was achieved with 80% sensitivity (95% CI 0.608-0.916), 58% specificity (95% CI 0.377-0.741) and 0.783 AUC (95% CI 0.675 to 0.891); with a further increased cutoff value of 1.02, specificity increases to 90% (95% CI 0.723-0.974) at the cost of decreased sensitivity of 60% (95% CI 0.408-0.768) (Figure 1 ). After the main group comparison, we found statistically higher (p < 0.001) mean nCBFPE in HGG (Figure 2 ) compared to metastasis ( Figure 3) ; however, the mean difference in nCBFL was statistically insignificant (p ¼ 0.125) ( Table 1) . ROC analysis results (Figure 1(b) ) indicated that when nCBFPE ¼ 1.2 was set as the threshold value, the best diagnostic performance in predicting HGG lesions was achieved with a sensitivity of 94% (95% CI 0.765-0.988), specificity of 83.3% (95% CI 0.645-0.937) and AUC of 0.94 (95% CI 0.86-1.00), while with a low cutoff value of 0.73, sensitivity increases to 100% (95% CI 0.859-1.00) at the cost of decreased specificity of 38% (95% CI 0.205-0.561). When HGG was compared to tuberculoma (Figure 4) , mean nCBFL and nCBFPE were higher in HGG compared to tuberculoma (p < 0.001) ( Table 1) . We also compared two closely resembled lesions, metastases and tuberculoma, and observed higher mean nCBFL in metastases compared to tuberculoma (p < 0.001) with no statistically significant (p ¼ 0.263) difference in mean nCBPE (Table 1) . A cutoff nCBFL value of 2.8 differentiated metastasis from tuberculoma with 87% sensitivity (95% CI 0.584-0.977), 84% specificity (95% CI 0.509-0.971), 87% positive predictive value (95% CI 0.584-0.977), 83% negative predictive value (95% CI 0.509-0.971) and 0.89 AUC (95% CI 0.74-1.00, p ¼ 0.001).
We found almost similar nCBFL and nCBFPE values in tuberculoma and NCC ( Figure 5 ) with no statistically significant difference (p ¼ 0.351 and p ¼ 0.295) ( Table 1) . We were not able to specifically compare between other non-neoplastic lesions such as abscess (Figure 6 ), tumefactive demyelinating lesion (TDL) (Figure 7) , and fungal granulomas (Figure 8 ) with neoplastic lesions because of the limited number of patients in our sample.
Discussion
In this study, we found significantly higher (p < 0.001) mean nCBFL and nCBFPE in the neoplastic group with a good ability of ASL to define neoplastic lesions when nCBFL of 1.89 was considered as the cutoff value (sensitivity 90% and specificity 73%). Although many brain perfusion studies have been reported in evaluation of tumors and a few on infections, most of [18] [19] [20] Floriano et al. 18 found higher (p < 0.001) rCBV in neoplastic (4.28 AE 2.11) than non-neoplastic lesions (0.63 AE 0.49) with a cutoff rCBV value of 1.3 (sensitivity 97.8% and specificity 92.6%) for predicting malignancy. Hourani et al. 20 found higher rCBV (4.9 AE 3.1) in high-grade tumors than non-neoplastic lesions (1.0 AE 0.4; p < 0.001) with a cutoff rCBV value of 1.5 (sensitivity 77.8% and specificity 91.7%) for predicting malignancy. The slightly higher nCBFL cutoff value in our study than in the other published studies might be because of patient age, immunological status, heterogeneity and variability of included lesions, degree of angiogenesis, scanning protocol, perfusion techniques and post-processing software used.
The next comparison between closely resembled HGGs and metastases showed statistically significant (p < 0.001) higher mean nCBFPE values in HGG while an insignificant difference in nCBFL (Table 1) . Glioblastoma multiforme (GBM) is the most common glial brain tumor, often having a similar imaging appearance as solitary metastases with heterogeneous enhancement and extensive perilesional edema. Gliomas are infiltrative in nature and show statistically significant higher peritumoral blood flow values secondary to neo-angiogenesis and plenty of tumorspecific extracellular matrix components. Brain metastases capillaries lack BBB resulting in extensive vasogenic edema in the absence of tumor cells, which further decreases microcirculation due to local pressure and accounts for a decrease in peritumoral rCBV and CBF. 8, 9, [21] [22] [23] [24] A recent prospective study by Lin et al. 25 using 3D PCASL documented significantly (p < 0.038) higher CBF values in the peritumoral regions of glioblastomas than those in metastases with a cutoff CBF of 1.92 (sensitivity 92.86% and specificity 100%). A retrospective ASL study by Sunwoo et al. 26 in 128 patients with GBM and metastases found significantly higher peritumoral blood flow in GBM. Our results are also consistent with two other ASL studies conducted by Weber et al. 10 and Bai et al. 11 that demonstrated significantly higher perilesional CBF in glioblastomas than metastases. Weber et al. 10 also demonstrated significantly higher microvessel density in GBM than brain metastases and suggested that ASL-derived CBF may estimate brain tumors' microvascular densities.
Mainly two factors contribute to decreased peritumoral perfusion in metastases. First, brain metastases capillaries do not possess the unique BBB that makes them highly leaky resulting in vasogenic edema in the absence of tumor cells, and second, the presence of local microcirculation compression by extravasated edema fluid. In HGG, peritumoral edema demonstrates impervious peritumoral neural vasculature with BBB breakdown, tumor infiltration and tumor-specific extracellular matrix components, possibly explaining the increased rCBV and CBF. 24, 27, 28 Bulakbasi et al. 29 reported perilesional rCBV cutoff ratios of 1.2 in differentiating metastases from high-grade glial tumors, respectively. In our study, the proposed reason for the increased nCBFPE in neoplastic lesions is due to increased vascularity following tumor infiltration in HGG as these lesions comprised the majority of the neoplastic lesions included. Similarly, perilesional blood flow values can be used to differentiate glial tumors from enhancing tuberculomas. Intra-axial tuberculomas are difficult to differentiate from primary brain tumors and metastases on conventional MRI. Tuberculomas were the most frequent non-neoplastic lesion in our study and showed decreased (p < 0.001) nCBFL and nCBFPE compared to HGG. Batra and Tripathi 30 reported high intralesional rCBV in tuberculomas like cerebral gliomas; however, perilesional rCBV was reported to be low in tuberculomas. Gupta et al. 31 reported raised rCBV in tuberculomas, which correlated with reactive neovascularization and increased vascular endothelial growth factor expression.
The comparison between two closely resembled lesions, metastases and tuberculoma, showed statistically significant (p < 0.001) higher nCBFL in metastases compared to tuberculoma (Table 1) while no statistically significant difference (p ¼ 0.263) in nCBFPE. Similar results shown by another retrospective study by Chatterjee et al. 15 and Shankhe et al. 14 in distinguishing metastases from tuberculomas using DSC found statistically significant high rCBV from the enhancing portion of metastases than in tuberculomas. However, the rCBV values from PE were not different between tuberculomas and metastases. The authors also reported that multidrug-resistant TB may demonstrate a drastic increase in rCBV value, and MR perfusion can help predict therapeutic response in patients with cerebral tuberculomas. 14, 32 NCC shows variable MRI appearances depending on the evolving stage of infection and closely resembles tuberculoma where both exist as endemic disease. Increased perfusion generally favors diagnosis of neoplastic lesion rather than NCC. Gupta et al. 33 demonstrated significant differences using dynamic contrast-enhanced MRI-derived perfusion parameters among all the clinically active stages of NCC and found the highest in the colloidal stage. We found no statistically significant difference in lesion and perilesional perfusion values between NCC and tuberculomas. To compare our results, we did not find any ASL study in the literature differentiating tuberculomas and NCC.
Sometimes, rim-enhancing brain abscesses mimic cystic brain neoplasms and metastases, making differentiation difficult on conventional MRI. PWI along with DWI is helpful and few studies have demonstrated higher rCBV values from cystic HGG and metastases over cerebral abscesses. 34 Erdogan et al. 35 reported low rCBV ratios from the capsular portion of abscesses as compared to HGG and metastases. In our study, we have reported lower nCBFL and nCBFPE values in cerebral abscess than HGG and metastases.
The clinical presentation of patients with TDL is variable and poses a diagnostic challenge to distinguish it from HGG on conventional MRI, which often follows biopsy. TDLs usually show decreased rCBV values in comparison to HGG; however, they can also present with elevated rCBV values and mimic HGG, making differentiation difficult. 36, 37 A recent study by Hiremath et al. 38 has shown lower mean rCBV in TDL (2.11 AE 1.12) compared to mean rCBV in HGGs (3.77 AE 1.65).
Although the results from our current study are encouraging, there are a few limitations that should be noted. First, a relatively small number of patients were included in each group and their subgroups. Henceforth, a large sample size would be necessary to further establish the role of ASL in differentiation of various intracranial lesions. Second, we did not have histopathological confirmation in most of the non-neoplastic lesions. However, histopathological confirmation in non-neoplastic lesions may be practically difficult and we suggest the utility of more noninvasive ASL imaging methods to improve the reliability of our current findings. Third, our study results might be biased because of manual ROI placement, which usually affects all ROI-based studies, although previous studies have shown that this method for the measurement of maximal abnormality provides the highest intra-and interobserver reproducibility in perfusion measurements. 39, 40 On the other hand, Emblem et al. reported higher interobserver agreement and diagnostic accuracy of histogram analysis compared with the hotspot method. 41 Fourth, ASL is an echo planar imagingbased technique so is inherently associated with low signal-to-noise ratio (SNR), lower temporal and spatial resolution and greater susceptibility artifacts. We used the 3D PCASL sequence, which is a fast spin echo-based readout and gives a better SNR, fewer susceptibility artifacts and better labeling efficiency. Our experience with ASL suggests that being non-contrast, it can be useful in different pathologies at the cost of only a few minutes.
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